Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease
Tau has a wide variety of essential functions in the brain, but this protein also plays a determining role in the development of Alzheimer's disease (AD) and other neurodegenerative diseases called tauopathies. This is due to its abnormal aggregation and the subsequent formation of neurofibrill...
| Autores: | , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/404013 |
| Acceso en línea: | http://hdl.handle.net/10261/404013 https://api.elsevier.com/content/abstract/scopus_id/85208758184 |
| Access Level: | acceso abierto |
| Palabra clave: | Colocalization P301S transgenic mice Immunocytochemistry hippocampus. http://metadata.un.org/sdg/3 Ensure healthy lives and promote well-being for all at all ages |
| id |
ES_595a683aca02b2bdff560f7d5ef3eacd |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/404013 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease |
| title |
Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease |
| spellingShingle |
Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease Merino-Serrais, Paula Colocalization P301S transgenic mice Immunocytochemistry hippocampus. http://metadata.un.org/sdg/3 Ensure healthy lives and promote well-being for all at all ages |
| title_short |
Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease |
| title_full |
Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease |
| title_fullStr |
Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease |
| title_full_unstemmed |
Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease |
| title_sort |
Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease |
| dc.creator.none.fl_str_mv |
Merino-Serrais, Paula Soria, José Miguel Arrabal, Cristina Aguirre Ortigado-López, Alfonso Esparza, María Ángeles García Muñoz, Alberto Hernández, Félix Ávila, Jesús DeFelipe, Javier León-Espinosa, Gonzalo |
| author |
Merino-Serrais, Paula |
| author_facet |
Merino-Serrais, Paula Soria, José Miguel Arrabal, Cristina Aguirre Ortigado-López, Alfonso Esparza, María Ángeles García Muñoz, Alberto Hernández, Félix Ávila, Jesús DeFelipe, Javier León-Espinosa, Gonzalo |
| author_role |
author |
| author2 |
Soria, José Miguel Arrabal, Cristina Aguirre Ortigado-López, Alfonso Esparza, María Ángeles García Muñoz, Alberto Hernández, Félix Ávila, Jesús DeFelipe, Javier León-Espinosa, Gonzalo |
| author2_role |
author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Universidad de San Pablo-CEU Banco Santander Cajal Blue Brain Instituto de Salud Carlos III Ministerio de Ciencia e Innovación (España) Ministerio de Economía y Competitividad (España) 0000-0001-5484-0660 Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] |
| dc.subject.none.fl_str_mv |
Colocalization P301S transgenic mice Immunocytochemistry hippocampus. http://metadata.un.org/sdg/3 Ensure healthy lives and promote well-being for all at all ages |
| topic |
Colocalization P301S transgenic mice Immunocytochemistry hippocampus. http://metadata.un.org/sdg/3 Ensure healthy lives and promote well-being for all at all ages |
| description |
Tau has a wide variety of essential functions in the brain, but this protein also plays a determining role in the development of Alzheimer's disease (AD) and other neurodegenerative diseases called tauopathies. This is due to its abnormal aggregation and the subsequent formation of neurofibrillary tangles. Tau hyperphosphorylation appears to be a critical step in its transformation into an aggregated protein. However, the exact process, including the cellular events that trigger it, remains unclear. In this study, we employed immunocytochemistry assays on hippocampal sections from AD cases and from tauopathy cases (Braak stage III) with no evidence of cognitive decline, and the P301S mouse model to investigate the colocalization patterns of Tau phosphorylated (p) at specific residues (S202-T205, S214, and T231) within the proline-rich region. Our results show pyramidal neurons in the hippocampus of P301S mice in which Tau is intensely phosphorylated at residues S202 and T205 (recognized by the AT8 antibody), but with no detectable phosphorylation at S214 or T231. These non-colocalizing neurons displayed intensely labeled aggregated pTau deposits distributed through the soma and dendritic processes. However, most of the hippocampal pyramidal neurons are labeled with pTauS214 or pTauT231 antibodies and typically showed a homogeneous and diffuse pTau distribution (not aggregated). This different labeling likely reflects a Tau conformational step, potentially related to the transition from a diffuse tau phosphorylation phenotype (Type 2) into an NFT-like or Type 1 phenotype. We further observed that dendrites of CA3 pyramidal cells are intensely labeled with pTau214 in the stratum lucidum, but not with AT8 or pTauT231. By contrast, analysis of tissue from AD patients or other human tauopathy cases (Braak stage III) with no evidence of cognitive decline revealed extensive colocalization with both antibody combinations in CA1. The complete or mature tangle development may follow a different mechanism in the P301S mouse model or may require more time to achieve the maturity state found in AD cases. Further studies would be necessary to address this question. |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025 2025 2025 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 Publisher's version info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/404013 https://api.elsevier.com/content/abstract/scopus_id/85208758184 |
| url |
http://hdl.handle.net/10261/404013 https://api.elsevier.com/content/abstract/scopus_id/85208758184 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
#PLACEHOLDER_PARENT_METADATA_VALUE# #PLACEHOLDER_PARENT_METADATA_VALUE# #PLACEHOLDER_PARENT_METADATA_VALUE# info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2021-127924NB-I00 info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2021-123859OB-I00 info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2020-113204GB-I00 Experimental neurology https://doi.org/10.1016/j.expneurol.2024.115049 Sí |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
Elsevier |
| publisher.none.fl_str_mv |
Elsevier |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869408608238698496 |
| spelling |
Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's diseaseMerino-Serrais, PaulaSoria, José MiguelArrabal, Cristina AguirreOrtigado-López, AlfonsoEsparza, María Ángeles GarcíaMuñoz, AlbertoHernández, FélixÁvila, JesúsDeFelipe, JavierLeón-Espinosa, GonzaloColocalizationP301S transgenic miceImmunocytochemistryhippocampus.http://metadata.un.org/sdg/3Ensure healthy lives and promote well-being for all at all agesTau has a wide variety of essential functions in the brain, but this protein also plays a determining role in the development of Alzheimer's disease (AD) and other neurodegenerative diseases called tauopathies. This is due to its abnormal aggregation and the subsequent formation of neurofibrillary tangles. Tau hyperphosphorylation appears to be a critical step in its transformation into an aggregated protein. However, the exact process, including the cellular events that trigger it, remains unclear. In this study, we employed immunocytochemistry assays on hippocampal sections from AD cases and from tauopathy cases (Braak stage III) with no evidence of cognitive decline, and the P301S mouse model to investigate the colocalization patterns of Tau phosphorylated (p) at specific residues (S202-T205, S214, and T231) within the proline-rich region. Our results show pyramidal neurons in the hippocampus of P301S mice in which Tau is intensely phosphorylated at residues S202 and T205 (recognized by the AT8 antibody), but with no detectable phosphorylation at S214 or T231. These non-colocalizing neurons displayed intensely labeled aggregated pTau deposits distributed through the soma and dendritic processes. However, most of the hippocampal pyramidal neurons are labeled with pTauS214 or pTauT231 antibodies and typically showed a homogeneous and diffuse pTau distribution (not aggregated). This different labeling likely reflects a Tau conformational step, potentially related to the transition from a diffuse tau phosphorylation phenotype (Type 2) into an NFT-like or Type 1 phenotype. We further observed that dendrites of CA3 pyramidal cells are intensely labeled with pTau214 in the stratum lucidum, but not with AT8 or pTauT231. By contrast, analysis of tissue from AD patients or other human tauopathy cases (Braak stage III) with no evidence of cognitive decline revealed extensive colocalization with both antibody combinations in CA1. The complete or mature tangle development may follow a different mechanism in the P301S mouse model or may require more time to achieve the maturity state found in AD cases. Further studies would be necessary to address this question.This work was supported by a grant from Fundación Universitaria San Pablo CEU-Banco Santander to GLE (FUSP-PPC-19-264E8B2F) and from the following grants to JDF: PID2021-127924NB-I00 funded by MCIN/ AEI/10.13039/501100011033; CSIC Interdisciplinary Thematic Platform - Cajal Blue Brain (PTI-BLUEBRAIN; Spain); and CIBERNED, ISCIII, CB06/05/0066. Work in the laboratory of JA is funded by grants from MCIN/AEI/10.13039/501100011033/FEDER, UE (PID2021- 123859OB-100). Work in the laboratory of FH is funded by grants from the Spanish Ministry of Economy and Competitiveness (Ministerio de Economía, Industria y Competitividad, Gobierno de España, PID2020- 113204GB-I00).Peer reviewedElsevierUniversidad de San Pablo-CEUBanco SantanderCajal Blue BrainInstituto de Salud Carlos IIIMinisterio de Ciencia e Innovación (España)Ministerio de Economía y Competitividad (España)0000-0001-5484-0660Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]202520252025info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionhttp://hdl.handle.net/10261/404013https://api.elsevier.com/content/abstract/scopus_id/85208758184reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Inglés#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2021-127924NB-I00info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2021-123859OB-I00info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2020-113204GB-I00Experimental neurologyhttps://doi.org/10.1016/j.expneurol.2024.115049Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/4040132026-05-22T06:33:51Z |
| score |
15,811543 |